NewsRx

Search our medical news database

Oncology Business Week

Susan Hasty, Publisher

Table of Contents . . . April 3rd, 2005

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Oncology Business Week | Other Publications

Agenix Limited - Biotech firm sells Milton Pharmaceuticals

Amgen - Neulasta trial results published in The Journal of Clinical Oncology

CancerVax Corporation - Biotech company reports fourth quarter net loss of $14.3M

Genzyme Corp - Company gets European marketing approval of Thyrogen for thyroid tissue ablation

Houston VA Medical Center - Diabetes triples risk of liver cancer

Immunicon Corp. - Prognostic factor for newly diagnosed metastatic breast cancer published

Max Delbruck Center for Molecular Medicine, Berlin - Tamoxifen-resistant breast cancer cells harbor distinct genetic changes

Medical University of Berlin - Genomic effects of 5-Aza-CdR on AML and MDS cells determined

Onyx Pharmaceuticals - Pharmaceutical company reports fourth quarter results, clinical progress

PharmaMar - Aplidin commences phase II clinical trials in prostate and bladder cancers

Progen Industries Limited - Anticancer drug development company appoints scientific advisory board

QLT Inc. - Sosei files Japan marketing authorization application for prostate cancer drug

QLT, Inc. - Eligard now available for treatment of prostate cancer

Sequenom, Inc. - Research collaboration to analyze diabetes, breast cancer genetic markers

iCAD, Inc. - Imaging company reports Q4 2004 record sales, gross margins and earnings

AVEO Pharmaceuticals - GenPath Pharmaceuticals changes name

Aichi Cancer Center - Immunogenic peptides in retroviral vectors may confound gene therapy

AntiCancer - Modified bacteria wreak havoc with cancer cells

Ardana - Successful results reported in phase II trial of Teverelix in prostate cancer

Aristotle University of Thessaloniki - Anastrozole assessed as therapy in obese postmenopausal women

Assisted Suicide - A death in Connecticut puts the spotlight on assisted suicide

BSD Medical Corp. - Cancer therapy system sold to German clinic

Bavarian Nordic - Further investment made in smallpox vaccine production

Baylor College of Medicine, Houston - MYCN directly modulated baseline MDM2 levels in neuroblastoma pathogenesis

Boston University - Dermal fibroblast proliferation studied, wound fluid suppression clarified

CHU, Dijon - Chemoembolization of large hepatocellular carcinoma was ineffectual

California Institute of Technology, Pasadena - Recent findings in proteomics described

Catholic University of the Sacred Heart, Rome - Thiocolchicine dimers active against cisplatin-resistant ovarian tumor cells

Cell Therapeutics, Inc. - Results to be reported from STELLAR 3 trial of Xyotax

Center Studio Prevenzione Oncology, Florence - HPV DNA found in prostate tissue suggests role in prostate cancer

ChemGenex Pharmaceuticals Ltd. - Positive trial data presented on anticancer compound, Quinamed

Chemical Diversity, Inc. - Targeting Hedgehog signaling pathway with small molecules is collaborative work

Chinese University of Hong Kong - Antifungal peptide inhibits leukemia proliferation and HIV-1-RT activity

Chung Shan Medical University, Taichung - H-Ras oncogene counteracted growth-inhibitory effect of genistein in T24 cells

Columbia Univ. College of Physicians & Surgeons - Pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis

ConAgra - Culturelle may prevent lesions that can lead to some forms of colon cancer

Cornell University - Study: Chemicals in apples could reduce the risk of breast cancer

Cornell University, New York - TNF blockade may be therapeutic for antiphospholipid syndrome complications

Creighton University - Genetic link possible cause of bone marrow cancer

Dana Farber Cancer Institute, Boston - Adenovirus-mediated caspase-8 gene transfer sensitizes cancer to TRAIL

Danish Cancer Society - Peptides from taxol resistance-related protein elicit T-cell responses

Drexel University, Doylestown - Glycoproteomic analysis discovers markers for early HBV-related liver cancer

Duke University, Durham - Combined use of EGFR and mTOR inhibitors diminishes glioblastoma growth

Federal University of Pernambuco - Peptidyl derivatives have antitumor activity

First Clinical Hospital of Jilin Univ., Changchun - Two-DE protein profiling used as analytical tool for leukemia 2 classification

Florida Pain Initiative - Florida coalition to advocate for better pain management

Fordham University, Bronx - Intermediate-type stem cells may be instrumental in tumor genesis and growth

Fox Chase Cancer Center, Philadelphia - Multidrug resistance protein studied, role in transport revealed

Fred Hutchinson Cancer Research Center, Seattle - Physical activity may reduce lung cancer risk among those with high exposure

Free University of Brussels - Metastasis suppressor properties of GPR54 elucidated

Fujirebio Diagnostics, Inc. - Diagnostics company launches blood test for mesothelioma

Georg-August University of Gottingen - Dendritic cells have limited potential in immunotherapy

German Cancer Research Center, Heidelberg - RGS-5 is activated in pericytes during active vessel remodeling

German Institute of Human Nutrition - Short-term weight changes increase risk of essential hypertension

Guy's Hospital, London - Rare case of primary intratesticular leiomyosarcoma in a mixed-race man reported

Hannover Medical School - Gene expression profiles can predict molecular treatment response

Hannover Medical School - Research add new data to cancer therapy body of knowledge

Hong Kong University of Science & Technology - The deleted in esophageal cancer 1 gene may be involved in cancer suppression

Hospital Santos Reyes, Burgos - Prior limitations of prostate cancer diagnosis solved by PET-CT technique

Hospital St. Louis, Paris - Competing risks approach estimates primary/secondary relapse following ABMT

Human Genome Sciences, Inc. - Patient enrollment completed for HGS-ETR1 phase II trial in non-Hodgkin lymphoma

Inst. for Myeloma & Bone Cancer Res., W. Hollywood - Zoledronic acid recommended as treatment for patients with bone metastases

Inst. of Cytology & Preventive Oncol., New Delhi - Reports add new data to cancer genetics research

Intarcia Therapeutics, Inc. - CAT study to examine combination hormonal therapy for advanced breast cancer

Intraop Medical, Inc. - European cancer centers form European Consortium for Research in IORT Studies

Istituto Nazionale Tumori - Human tumor antigens recognized by T cells listed

Jikei University Hospital - CD2+ tetraploid APL variant with double (15;17) translocations reported

Johns Hopkins University - Vinorelbine showed no clinical influence on patients with metastatic melanoma

Kaohsiung Medical University - Eliminating arsenic in drinking water decreased lung cancer mortality in Taiwan

KineMed - Data on cellular progression of chronic lymphocytic leukemia published

Korea Research Institute, Taejon - BRD-glucan appears to be a promising immunochemotherapeutic antitumor agent

Kumamoto University - Intravenous administration of the SMA-THP enhanced effect of pirarubicin

Kyoto Prefectural University of Medicine - Findings advance knowledge in oncology research

La Jolla Inst. for Allergy & Immunology - Scientists' findings show regulation of immune cell memory

Louisiana State University, Baton Rouge - Therapies that regulate heparanase can control malignant melanoma

Lymphoma - First case of Langerhans cell histiocytosis in sequential discordant lymphoma

M.D. Anderson Cancer Center - Role of PI3-AKT signaling in genomic effects of trastuzumab determined

M.D. Anderson Cancer Center - Study discusses keys to increasing testing accuracy in breast cancer

Maruko General Hospital - Eradication of Helicobacter pylori affected the ongoing mutation of IgH

Massachusetts Institute of Technology - Nuclear reactor employed as a cancer cure

Mayo Clinic - Novel chromosomal alterations identified through array CGH analysis

McGill University - Second most fatal cancer sometimes inherited

Medical College of Georgia - Drug that hinders blood vessel growth under study in ovarian cancer

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook